UK to use antiviral drug remdesivir to treat some COVID-19 patients

19:23   27 May, 2020

The UK in collaboration with Gilead Sciences will use remdesivir in the treatment of certain COVID-19 patients that it is likely to be beneficial, the country's department of health said.

According to the department, early data from clinical trials around the world showed that the drug could shorten the recovery time of COVID-19 patients by four days, Reuters reported.

“This is probably the biggest step forward in the treatment of coronavirus since the crisis began,” health minister Matt Hancock told a government news conference.

“These are very early steps, but we are determined to support the science and back the projects that show promise.”

© Medicine